Like him, you don't engage on the key issues. Which are that the FDA has put so many roadblocks and delays that MSB treatments couldn't get clear air to get a true control group. How can you demonstrate efficacy with that going on?
The recruitment problems were indicative but it was difficult to see how this was playing out because MSB and certainly not shareholders, aren't on the ground. But we can see the delays clearly.
The truth is that there are people in here who shift colours rapidly and go on the attack against anyone who is calling for calm and rational analysis.
Ann: Mesoblast Update on COVID-19 ARDS Trial, page-332
-
- There are more pages in this discussion • 744 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
96.3¢ |
Change
0.013(1.32%) |
Mkt cap ! $1.090B | |||
| Open | High | Low | Value | Volume |
| 94.5¢ | 96.5¢ | 93.5¢ | $1.236M | 1.292M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 28786 | 96.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 96.5¢ | 77098 | 20 |
View Market Depth
| Last trade - 12.05pm 12/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |